BPC 157 And TB 500: Background, Indications, Efficacy, And Safety GlobalRPH BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or In this video, I discuss the dosage recommendations for BPC 157. Although there are no human clinical trials on optimal dosing, we rely on animal literature and anecdotal evidence. For oral PDF) Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 + TB 500 Combination: Benefits, Differences, and When to Use Both Revolution Health & Wellness Peptide Therapy for Pain Management and Healing Core Medical & Wellness